Atorvastatin Calcium
Product Images NDC 70934-614

5 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 614 90 Master Bottle Label Approval Rev A 06 20)

Label (70934 614 90 Master Bottle Label Approval   Rev A 06 20)
Atorvastatin Calcium Tablets USP 20 mg label from Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label indicates the product contains 90 tablets, is Rx only, and provides storage instructions to keep at 20°-25°C. Additional details include a barcode, NDC number 70934-614-90, and manufacturer information.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
A line graph comparing cumulative incidence percentages over approximately 3.5 years between Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing a lower cumulative incidence compared to the dashed line for placebo. The graph includes a hazard ratio (HR) of 0.64 with confidence intervals (0.50-0.83) and a p-value of 0.0005.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
A Kaplan-Meier cumulative hazard curve comparing Atorvastatin and placebo over four years of follow-up. The x-axis shows time in years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio (HR 0.63 with 95% CI 0.48-0.83) and p-value (0.001), indicating statistical comparison between treatments.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
A line graph comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, ranging from 0 to 5, while the y-axis shows the percentage of subjects experiencing the event, up to 0.2%. Two lines depict event rates: a dashed line for Atorvastatin 10 mg and a solid line for Atorvastatin 80 mg, with the higher dose showing a slightly lower event rate. Statistical values HR 0.78 (0.69-0.89) and P=0.0002 are displayed on the graph.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)
Chemical structure of Atorvastatin Calcium, showing its detailed molecular arrangement including phenyl groups, hydroxyl groups, and calcium ion complexation, annotated with calcium and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.